SCHEMBL11112482

SCHEMBL11112482

CC(OC(=O)/C=C\C(=O)O)C(NC(C)(C)C)Oc1nsnc1N1CCOCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.56
BLM P54132 1/20 0.56
ALDH1A1 P00352 4/20 0.48
MAPT P10636 2/20 0.48
KDM4E B2RXH2 1/20 0.48
HPGD P15428 1/20 0.48
ALOX15 P16050 1/20 0.48
HSD17B10 Q99714 1/20 0.48
CYP1A2 P05177 1/20 0.44
ADRB2 P07550 1/20 0.44
ADRB1 P08588 1/20 0.44
CYP3A4 P08684 1/20 0.44
HTR1A P08908 1/20 0.44
CYP2D6 P10635 1/20 0.44
ADRB3 P13945 1/20 0.44
NFKB1 P19838 1/20 0.44
DRD1 P21728 1/20 0.44
SIGMAR1 Q99720 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
LIPA P38571 5/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5272608 0.96 ALDH1A1 (0.52) SMN1; SMN2BLMALDH1A1MAPTKDM4E
SCHEMBL8793041 0.80 TDP1 (0.56) SMN1; SMN2BLMALDH1A1MAPTKDM4E
SCHEMBL10993216 0.80 TDP1 (0.56) SMN1; SMN2BLMALDH1A1MAPTKDM4E
SCHEMBL3796363 0.80 TDP1 (0.56) SMN1; SMN2BLMALDH1A1MAPTKDM4E
SCHEMBL1588408 0.77 SMN1; SMN2 (0.78) SMN1; SMN2BLMALDH1A1MAPTKDM4E
SCHEMBL22260724 0.77 SMN1; SMN2 (0.78) SMN1; SMN2BLMALDH1A1MAPTKDM4E
SCHEMBL7591866 0.77 SMN1; SMN2 (0.78) SMN1; SMN2BLMALDH1A1MAPTKDM4E
SCHEMBL4434481 0.77 SMN1; SMN2 (0.78) SMN1; SMN2BLMALDH1A1MAPTKDM4E
SCHEMBL1588404 0.77 SMN1; SMN2 (0.78) SMN1; SMN2BLMALDH1A1MAPTKDM4E
SCHEMBL25063558 0.76 SMN1; SMN2 (0.73) SMN1; SMN2BLMALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4195085-A Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate MERCK & CO., INC. (US) 1980-03-25 US claimed
EP-0105996-A1 Ophthalmic compositions for treating elevated intraocular pressure MERCK & CO. INC. (US) 1984-04-25 EP disclosed
US-4195085-A Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate MERCK & CO., INC. (US) 1980-03-25 US disclosed
US-4195085-A Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate MERCK & CO., INC. (US) 1980-03-25 US disclosed